TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Takara Bio Inc. ( (JP:4974) ) is now available.
Takara Bio Inc. reported its consolidated financial results for the three months ending June 30, 2025, showing a 9.1% increase in net sales compared to the previous year, despite experiencing operating and ordinary losses. The company also announced the inclusion of Curio Bioscience, Inc. as a new subsidiary, indicating a strategic expansion in its business operations.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen830.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. is a company listed on the Tokyo Stock Exchange, operating in the biotechnology industry. It focuses on developing and providing innovative biotechnology products and services, with a market emphasis on genetic research and related applications.
Average Trading Volume: 249,214
Technical Sentiment Signal: Sell
Current Market Cap: Yen110.3B
Find detailed analytics on 4974 stock on TipRanks’ Stock Analysis page.